Skip to main content
Clinical Trials/CTRI/2019/12/022487
CTRI/2019/12/022487
Recruiting
Phase 3

To study the efficacy of preoperative Pregabalin on perioperative pain and haemodynamic stability in patients undergoing cardiac surgery

VMMC and Safdarjung Hospital New Delhi0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: I251- Atherosclerotic heart disease of native coronary arteryHealth Condition 2: I059- Rheumatic mitral valve disease, unspecified
Sponsor
VMMC and Safdarjung Hospital New Delhi
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
VMMC and Safdarjung Hospital New Delhi

Eligibility Criteria

Inclusion Criteria

  • Patient undergoing CABG, single valve replacement on Cardiopulmonary bypass machine.

Exclusion Criteria

  • \-Left ventricular Ejection Fraction (LVEF) less than 50%
  • \-Co\-morbidities like severe respiratory disorder, obstructive sleep apnea, hepatic insufficiency, renal disease, cerebrovascular disease.
  • \-Preoperative cardiomyopathies, left bundle branch block, left main artery blockage, preoperative intra\-aortic balloon pulsation (IABP) or temporary pacing .
  • \-History of prolonged opioid use, gabapentin, pregabalin before surgery.
  • \-Difficult airway Mallampati grade III \& IV
  • \-Body mass Index (BMI) \>\=30

Outcomes

Primary Outcomes

Not specified

Similar Trials